ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Nov 6, 2014
Sprint Falls Back Down to Under $5 Per Share
Sprint has been one of the worst performing stocks in 2014.
Nov 5, 2014
Alibaba Still Has Upside to $125+ Per Share
The Chinese Internet giant debunks the myth that you can’t make money on initial public offerings.
Nov 4, 2014
AIG Still Our Best Idea in Insurance
The insurance giant continues to trade below book value. Shares remain attractive.
Nov 3, 2014
Apple: “We’ve Got a New Watch Launch Coming in the Spring”
News leaked that the new Apple Watch will launch in the spring, an update from previous expectations of “early 2015.” Though the news is a bit inconsequential, it has shares of Apple approaching $110 each.
Nov 3, 2014
How About Teva Pharmaceuticals?
Teva Pharma has been one of the best performers thus far in 2014, and we trust many of you have profited.
Nov 2, 2014
The November Edition of the Dividend Growth Newsletter!
The November edition of the Dividend Growth Newsletter is now available.
Nov 1, 2014
Dividend Increases for the Week Ending October 31
Let's take a look at dividend increases for the week ending October 31.
Oct 31, 2014
We’re At New Highs Again
The S&P 500 is probably the most resilient is has ever been in history. Our guard is still up.
Oct 30, 2014
Nothing Wrong at the Monthly Dividend Company
American Realty Capital’s pain has become Realty Income’s gain.
Oct 30, 2014
Best Ideas Portfolio Holding Visa Doesn’t Disappoint
There are very few firms, if any, that have a more attractive business model than Visa’s.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.